News Listing

AMJEVITA™ (ADALIMUMAB-ATTO), FIRST BIOSIMILAR TO HUMIRA®, NOW AVAILABLE IN THE UNITED STATES- Amgen (NASDAQ:AMGN) today announced AMJEVITA™ (adalimumab-atto), a biosimilar to Humira®* (adalimumab), is now available in the United States. AMJEVITA was the first biosimilar to Humira approved by the U.S. Food and Drug Administration (FDA), in 2016.2,3....

A new year is upon us and the usual resolutions are beginning to follow us around: go to the gym, eat healthier, drink less caffeine, sleep more. The problem is that resolutions only hold our interest until mid-February before the excitement of the new year ends. In this post, we’ll share five goals you can easily accomplish while on the job that will boost your health in 2023.

It’s no wonder holiday season stress is an issue for so many: the shopping and crowds, the office parties, and bustling medical practices. It’s so easy to feel not so wonderful during this most wonderful time of the year, especially when you are managing a busy medical office.

The holiday season is filled with celebrations and happenings (professional and otherwise) that can keep one on the move throughout November and December.

The United States Senate Committee of Finance released their report titled “Deceptive Marketing Practices Flourish in Medicare Advantage” and excerpts from the NORM Advocacy Letter have been included on pages 11-12.

PAYER BARRIERS LIMIT TIMELY ACCESS Authored by Aurinia Pharma U.S., Inc. 

Timely access to therapy can be difficult to achieve. With Aurinia, office staff have direct support from Specialty Pharmacies (SPs) to get the medicine that their patients need.

Reducing stress at your medical practice can be a daunting task since stress is an intrinsic part of the medical world.